Epigenetic Modulator Development

Epigenetic modifications play an important role in prostate tumor development and progression. Alfa Cytology is committed to providing a comprehensive one-stop development service for epigenetic modulator development services in prostate cancer.

Introduction to Epigenetic Modulator

Epigenetic modifications, including DNA methylation patterns and post-translational modification of histone tails, have emerged as significant participants in PCa progression. In order to block or reverse epigenetic aberrations that promote cancer, much effort has been directed toward understanding epigenetic modifications that are possible to reverse.

Fig. 1 Graphic summary of epigenetic regulation in prostate cancer and potential therapeutic options. (Ge, R., et al. 2020)

Epigenetic Modulator Development for Prostate Cancer

Significant advances have been made in targeted drug therapies for epigenetic regulation in prostate cancer.

Our Services

At Alfa Cytology , our scientists have been deeply involved in epigenetic modulator development in prostate cancer for many years. And we have a professional team to provide you with 24-hour end-to-end development services to ensure that the entire epigenetic modulator development process is fast-tracked.

Small Molecule Inhibitors Development

Offering complete development of small molecule inhibitors, from discovering lead compounds to enhancing their chemistry, screening, and adjusting them for better performance.

One-stop Solutions for Epigenetic Modulator Development

Alfa Cytology offers a full range of services for therapies development targeted to epigenetic modulator in prostate cancer, including but not limited to the following.

Drug Development

• Drug Discovery
• Efficacy Evaluation
• DMPK / ADME
• Safety Assessment

Tumor Models

• Tumor-on-a-chip
• Humanized Model
• Genetically Engineered Model
• Syngeneic Model

Diagnostic Development

• Biomarker Discovery
• Omics Analysis
• HHR Detection

Epigenetic Factors Implicated in Prostate Cancer

The main epigenetic factors associated with prostate cancer are summarized below.

Our Advantages

Our company is committed to providing customized one-stop services to accelerate your project development. With professional knowledge, we are committed to providing you with reliable experimental solutions, efficiently providing you with round-the-clock development services to ensure that your development is of low cost and confidentiality.

Qualified Experiment

Timely Delivery

Cost-Effective Services

Highly Confidential

At Alfa Cytology, our mission is to advance prostate cancer therapy development by providing a one-stop service for epigenetic modulator development. If you are interested in our services, please don't hesitate to contact us for further information and pricing details.